Skip Ribbon Commands
Skip to main content

Key Milestones

  • Launches Fundraising Capital Campaign to raise $150M for Patient Care, Education and Research

  • Ground breaking ceremony for the New NCCS Building. The new comprehensive proton therapy facility located within the new building is named the Goh Cheng Liang Proton Therapy Centre.
  • Founding Director, Prof Soo Khee Chee relinquishes the appointment as Director of NCCS on 26 November 2017. Prof William Hwang is appointed as Medical Director of NCCS on the same date

  • ​NCCS Awards contract for Proton Beam Therapy System to Hitachi Asia Ltd.

  • ​Collaborates with ASLAN Pharmaceuticals to research and develop therapies for Asia-Prevalent Tumour Types
  • Wins Service Excellence Medallion Award - the first healthcare institution in Singapore to receive this award.

  • ​Collaborates with Clearbridge BioMedics, together with the Pathology Department of the Singapore General Hospital, to set up region’s first Circulating Tumour Cell Centre of Research Excellence (CTC CoRE).
  • Signs Goyang Declaration in Seoul to push for a Tobacco-Free Generation (TFG) in Asia.
  • Receives $50 million donation from the Goh Foundation for setting up of new Proton Beam Treatment Centre and for cancer research.
  • Launching of the Comprehensive Liver Cancer Clinic (CLCC) to improve service to liver cancer patients.
  • ​Signs Master Research Collaboration Agreement with Singapore General Hospital and Australia’s Sirtex Medical Pte Ltd to explore the potential of a new technology called Carbon Cage Nanoparticles.
  • Launching of NCCS Oncology Clinic @ CGH.
  • Sets up the Integrated Translational Oncology Network together with Bayer Heathcare,Cancer Science Institute of Singapore,Duke-NUS Medical School, National University Cancer Institute, Singapore, Singapore General Hospital, A*STAR’s Singapore Bioimaging Consortium.
  • JCI grants re-accreditation.
  • ​Partners BNP Paribas to launch the first NCCS Surgical Oncology Conference.
  • Announces its plans to offer Proton Therapy to patients in 2017/2018.
  • Introduces Intraoperative Radiotherapy (IORT) for breast cancer patients.
  • Opens Centre for Peritoneal and Pelvic Cancers.
  • Partners Wellcome Trust Sanger Institute (UK) and Van Andel Research Institute (USA) and discovers a new gene that is mutated in one out of three cancer patients with renal cancers.
  • Collaborates with NTU to produce ‘Sharing Plates’, a cookbook for cancer patients.
  • Embarks on genome sequencing project to study possible disease pathways.
  • The magnetic guided focus ultrasound (MRgFUS), a new non-invasive treatment for prostate cancer is pioneered.
  • Receives People Developer re-certification for its business excellence in adopting a holistic approach to managing people and achieving high performance.
  • A comprehensive geriatric assessment is introduced to elderly patients with colorectal, lung and genitourinary cancers to assess their suitability for treatment.
  • The Breast Cancer Survivorship Programme, which enables patients to receive comprehensive disease surveillance assistance from Advanced Practitioner Nurses is introduced.
  • Holds its first charity concert “Rays of Hope’ and raised $3.7 million.
  • A germ-free lab, to support research on bacteria and mammalian-microbe interactions is set up.
  • The biennial gala dinner ‘Colours of Hope’, is held with Prime Minister Lee Hsien Loong as Guest of Honour.
  • ​Crafted its new Vision and Mission.
  • Embarked on its Disney service quality excellence.
  • A Phase 3 Clinical Trial on Colorectal Cancer using aspirin that will involve 2,660 subjects is introduced by Dr Toh Han Chong, Head of Medical Oncology and Dr John Chia, Medical Oncologist to evaluate the efficacy of aspirin in reducing the risk of recurrence of colorectal cancer post surgery and chemotherapy.
  • Receives accreditation from the Joint Commission International (JCI). It is the only national cancer centre in the region to be accorded the highest accolades for healthcare standards on patient safety and clinical governance.
  • Presents its proposal to deny the use of tobacco products for citizens born in or after the year 2000. The proposal was presented at the Singhealth-Duke-NUS Scientific Congress to various stakeholders.
  • Kicks off the JCI accreditation process in January.
  • The BNP Paribas-NCCS Regional Fellowship Programme is being launched. The first programme is conferred to a physician from Vietnam.
  • Wall of Hope, a wall mural which showcased the ceramic tiles made by patients, relatives, staff and students was unveiled.
  • A gala dinner, “Gala of Hope”, is held in conjunction with NCCS’s 10th Anniversary with President S R Nathan as Guest-of-Honour.
  • Auditorium is renamed Peter and Mary Fu Auditorium in acknowledgement of their donation of $5 million.
  • Organised the first Mammothon in conjunction with the Breast Cancer Awareness Month.
  • Tomotherapy, a type of radiation therapy that delivers more precise radiation treatment to cancerous site is introduced in the Department of Radiation Oncology.
  • ​A new technique, known as the Image-Guided Radiotherapy (IGRT), that enhances cancer control with lesser side effects is introduced.
  • Enters into a collaborative agreement that spans both clinical and preclinical development activities with AstraZeneca and the National University Hospital to develop anti-cancer compounds. The partnership also includes a Training Programme placement with the Manchester Cancer Research Centre to train a pool of clinical research professionals.
  • Partners Four Seasons Hotel Singapore and The Regent Singapore for the first time, on the annual Run for Hope to raise funds for cancer research.
  • Launches its first Liver Cancer Awareness Month.
  • Lien Centre for Palliative Care is opened by Minister for Health Khaw Boon Wan.
  • ​Geriatric Oncology Programme is established.
  • Signs an international collaboration agreement formalising an alliance to customise Asian patients’ cancer drug response, with the Van Andel Research Institute (VARI), based in Michigan, USA.
  • Humphrey Oei Institute of Cancer Research (HOICR) is established and embraces the three founding research divisions: Cellular and Molecular Research, Medical Sciences and Clinical Trials and Epidemiological Sciences.
  • ​Partners Flinders University of South Australia to offer Singapore’s first interdisciplinary university course (Postgraduate Specialist Programme) for doctors and nurses in palliative care.
  • A 64-slice Multi-Detector Computed Tomography (MDCT) is acquired to enable early detection and treatment of cancer.
  • The “I Can” campaign is launched to highlight that life after cancer is a Reality.
  • A MOU is signed with Rajiv Gandhi Centre for Biotechnology and Regional Cancer Centre in Thiruvananthapuram (India) to collaborate biomedical research and to study head and neck cancers.
  • Leads Singapore’s first bench-to-bedside Dendritic Cell Vaccine trial that produces encouraging results for advanced colon cancer patients.
  • The Health Professionals and Undergraduates (HPU) Education Unit is established to provide training opportunities for medical students to learn from veteran medical staff and clinicians.
  • ​Signs a landmark agreement with eight Asian National Cancer Centres to collectively embark on cancer prevention advocacy, cancer research, training as well as collaboration with World Health Organization and International Agency for Research on Cancer (IARC). NCCS also becomes the secretariat for the Asian National Cancer Centres Syndicate.
  • Partners Children Cancer Foundation and KKH Women and Children’s Hospital for research on rhabdomyosarcoma, a fast growing malignant tumour that affects children.
  • ​Singapore’s first linear accelerator with Intensity Modulated Radiotherapy (IMRT) and Respiratory Gating capabilities to improve tumour coverage and decrease the side effects of treatment is introduced.
  • The 1st Lung Cancer Awareness Month is launched.
  • Pioneers a new technique, Photodynamic Diagnosis and Treatment (PDT) that uses fluorescence diagnosis and drug-induced light therapy to diagnose and treat cancer.
  • ​Plays a key role in the national crisis management of SARS.
  • ​Cryopreservation Laboratory is established.
  • ​Department of Psychosocial Oncology is established.
  • ​Becomes part of Singapore Health Services (Singhealth), one of two Singapore’s public health care delivery system.
  • Mammography Suite is established.